Screening low-risk individuals for coronary artery disease

Chintan S Desai1, Roger S Blumenthal, Philip Greenland

  • 1Johns Hopkins Hospital, Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA, cdesai6@jhmi.edu.

Insights

Many cardiovascular events occur in "low-risk" individuals. While coronary artery calcium (CAC) and ankle-brachial index (ABI) show promise for improved risk assessment, routine screening is not recommended currently.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Diagnostics

Background:

  • A significant number of cardiovascular events occur in individuals deemed low-risk by traditional factors.
  • This highlights a need for improved early detection and risk assessment strategies in this population.
  • Existing risk factors may underestimate the true cardiovascular risk for many individuals.

Purpose of the Study:

  • To evaluate the utility of additional diagnostic tests for improving cardiovascular risk assessment in low-risk individuals.
  • To explore the potential of coronary artery calcium (CAC) score, ankle-brachial index (ABI), and high-sensitivity C-reactive protein (hsCRP) in this context.

Main Methods:

  • Review of existing data on the effectiveness of CAC, ABI, and hsCRP in low-risk populations.
  • Analysis of the potential impact of these tests on risk classification and early detection of coronary artery disease.

Main Results:

  • Coronary artery calcium (CAC) and ankle-brachial index (ABI) show potential for improving risk classification among low-risk individuals.
  • These tests may help identify higher-risk individuals within the broader low-risk group.
  • Data supporting the routine use of these additional tests in low-risk populations remain sparse.

Conclusions:

  • While CAC and ABI show promise for enhanced risk stratification, routine use is not currently recommended for low-risk individuals.
  • Further clinical trials are needed to establish the definitive role and efficacy of these tests in this population.
  • Current evidence does not support widespread screening with CAC, ABI, or hsCRP in asymptomatic low-risk individuals.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741